Prediction of drug transport processes using simple parameters and PLS statistics -: The use of ACD/logP and ACD/ChemSketch descriptors

被引:72
作者
Österberg, T [1 ]
Norinder, U [1 ]
机构
[1] AstraZeneca R&D Sodertalje, SE-15185 Sodertalje, Sweden
关键词
ACD/logP; ChemSketch; PLS; human jejunal permeability; Caco-2 cell permeability; brain-blood partitioning; P-glycoprotein; IAM chromatography; solubility;
D O I
10.1016/S0928-0987(00)00189-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A method of modelling and predicting biopharmaceutical properties using simple theoretically computed molecular descriptors and multivariate statistics has been investigated for several data sets related to solubility, IAM chromatography, permeability across Caco-2 cell monolayers, human intestinal perfusion, brain-blood partitioning, and P-glycoprotein ATPase activity. The molecular descriptors (e.g. molar refractivity, molar volume, index of refraction, surface tension and density) and logP were computed with ACD/ChemSketch and ACD/logP, respectively. Good statistical models were derived that permit simple computational prediction of biopharmaceutical properties. All final models derived had R-2 values ranging from 0.73 to 0.95 and Q(2) values ranging from 0.69 to 0.86. The RMSEP values for the external test sets ranged from 0.24 to 0.85 (log scale). (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:327 / 337
页数:11
相关论文
共 39 条
[31]   A METHOD TO DETERMINE THE ABILITY OF DRUGS TO DIFFUSE THROUGH THE BLOOD-BRAIN-BARRIER [J].
SEELIG, A ;
GOTTSCHLICH, R ;
DEVANT, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (01) :68-72
[32]  
SJOBERG P, 1997, COMPUTER ASSISTED LE, P83
[33]   Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine [J].
Sparreboom, A ;
vanAsperen, J ;
Mayer, U ;
Schinkel, AH ;
Smit, JW ;
Meijer, DKF ;
Borst, P ;
Nooijen, WJ ;
Beijnen, JH ;
vanTellingen, O .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :2031-2035
[34]  
STENBERG P, 1999, J CONTROL RELEASE, V65, P231
[35]  
Tavelin S, 1999, J PHARMACOL EXP THER, V290, P1212
[36]   Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier [J].
Terao, T ;
Hisanaga, E ;
Sai, Y ;
Tamai, I ;
Tsuji, A .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (10) :1083-1089
[37]   Blood-brain barrier function of P-glycoprotein [J].
Tsuji, A ;
Tamai, I .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 25 (2-3) :287-298
[38]   Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters.: A multivariate data analysis approach [J].
Winiwarter, S ;
Bonham, NM ;
Ax, F ;
Hallberg, A ;
Lennernäs, H ;
Karlén, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (25) :4939-4949
[39]  
Wold S., 1993, 3D QSAR DRUG DESIGN, P523, DOI DOI 10.1007/0-306-46858-1